immune systems, and therefore are more susceptible to sickness more often. Therefore, the older population needs to be added and thus segmented into several different age groups that will help give clear indications as far as age and its influence on contracting the flu virus, and whether or not the vaccine is effective. For example, splitting people up into age groups such as ages 0-10 years, 10-20 years, 20-30 years, and 65 years and older, along with factoring in their occupations and daily activities, and then administering the same tests used in the experiment. This will be far more efficient in figuring out how the vaccine helps or does not help people of all ages rather than just a set age group such as children. As someone who has doubts about the flu vaccine, I believe that more evidence must be found across particular age groups to prove the quality and the effectiveness of the vaccine on individuals at all stages of life. Field mentions that his study was limited to a private pediatric practice and the information was gathered over a 1-year period. 1 To expand upon this, a larger, more diverse and broad sample must be used to show the efficacy and validity of the flu vaccine. This study was a huge step in the right direction in bringing about awareness of the influenza vaccine and its capabilities. With the changes mentioned above, the vaccine's influence can be far more prevalent and potentially prevent a contagious and frequently diagnosed respiratory disease in America.
RESUMOObjetivo: Avaliar a eficácia de hipoclorito 1% como um agente de desinfecção ambiental para controlar Acinetobacter em um hospital onde este microrganismo é endêmico. Métodos: Uma avaliação foi realizada em três diferentes períodos: 10 meses antes, durante 3 meses e 5 meses após a intervenção com a higienização do ambiente, usando hipoclorito de 1% em todas as unidades do hospital. Os dados sobre infecção (pneumonia, infecção do trato urinário e bacteremia) foram apresentados como número por 1000 pacientes-dia. Resultados: A taxa de infecção Acinetobacter eram 16,7 por 1000 pacientes-dia antes da intervenção, 5,1 por 1000 pacientes-dia durante a intervenção e 25,0 por 1000 pacientes-dia de cinco meses após a intervenção de hipoclorito. A intervenção hipoclorito resultou numa redução significativa na infecção por Acinetobacter em todos os sítios (urinária, bacteremia e pneumonia) (p <0,05). Conclusão: hipoclorito foi eficaz na redução temporária da taxa de Acinetobacter infecção.Palavras--Chaves: Hipoclorito. Controle de Infecção. Infecção. Acinetobacter. Surto. ABSTRACTObjective: Evaluate the effectiveness of 1% hypochlorite as an environmental disinfection agent to control Acinetobacter infection in a hospital where this microorganism is endemic. Methods: An interventional prospective at three different periods: 10 months before, 3 months during and 5 months after intervention with environmental hygienization using 1% hypochlorite in all units of the hospital. The normal routine for infection control remained the same during the intervention. Data on infection (pneumonia, bacteremia and urinary tract infection) were presented as number per 1000 patient-days. Results: The rate of Acinetobacter infection were 16.7 per 1000 patient-days before intervention, 5.1 per 1000 patient-days during intervention and 25.0 per 1000 patient-days five months after hypochlorite intervention. The hypochlorite intervention resulted in a significant reduction in Acinetobacter infection, including all sites (urinary, bacteremia and pneumonia) (p < 0.05). Conclusion: Hypochlorite was effective in reducing the rate of Acinetobacter infection during the disinfection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.